intra thecal morphine
PreclinicalSmall molecule
intra thecal morphine is one of 6 small molecule programs targeting Knee Arthroplasty. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
5
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
6 competitors in Knee Arthroplasty
#DrugCompanyPhaseTrials
1Decadron
AAspen Global Incorporated
Approved
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Approved
EXPAREL
Pacira Pharmaceuticals, IncApproved
Intrathecal Morphine
Pacira Pharmaceuticals, IncPreclinical
Intrathecal Fentanyl
MMansoura University
Preclinical
intra thecal morphine
UUniversity College Hospital Galway
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Erector Spinae Plane Block1 trial
Ultrasound Guided Erector Spinae Plane Block vs Intrathecal Morphine
Completed·—·Phase 4·NCT05218733·120 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for intra thecal morphine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details